What This Means
This research suggests that people diagnosed with invasive cancer face a substantially higher chance of having an ischemic stroke (a stroke caused by a blood clot blocking blood flow to the brain) in the year following their diagnosis compared to the general population. Using data from over 182,000 Israeli adults linked across national cancer and stroke registries, the study found that the overall stroke risk was 1.8 times higher than expected, and that this risk was especially concentrated in the first three months after cancer diagnosis, when it reached 2.5 times the expected rate.
The elevated stroke risk varied considerably depending on the type of cancer, the patient's age, and how advanced the cancer was. Pancreatic cancer carried nearly six times the expected stroke risk, and lung cancer carried nearly four times the expected risk, while breast cancer was associated with lower stroke risk. Younger cancer patients (ages 40–54) showed a greater relative increase in stroke risk compared to older patients, and those with metastatic (widely spread) cancer had more than twice the stroke risk of those with localized disease. In absolute terms, about 0.62% of cancer patients had a stroke within one year, translating to roughly 1 in 160 patients.
This research suggests that the period immediately following a cancer diagnosis may be an important time to assess and monitor patients for cerebrovascular risk. The findings point to specific high-risk groups — particularly those with pancreatic or lung cancer, younger patients, and those with advanced-stage disease — who might benefit most from closer monitoring. Incorporating cerebrovascular risk assessment into standard oncologic care could help identify patients who might benefit from preventive strategies, though the study does not test any specific interventions.